$25.13
-0.57-2.22%
Last update: Oct 12, 7:27 PM
$24.55
-1.15-4.47%
Beam Therapeutics Inc
BEAMNASDAQ
Wall Street analyst price targets and consensus rating for Beam Therapeutics (BEAM).
Price Target Range — 12 Quarters
Analyst Consensus — 18 Analysts
Rating Trend — Last 9 Months
